6-Ethylchenodeoxycholic acid

• Post Date:

  Oct 14,2014

• Expiry Date:

  Apr 12,2015

• Detailed Description:

  Cas No. :459789-99-2 Specs:98%
  We are the first company in domestic to approach this product at the moment.
  
  Sample is available on Mid-Oct, 2014.
  
  Good service, your good business partner.
  
  
  
  Other Drug Names: OCA, Intercept; DSP-1747; FXR agonists, Intercept; INT-747; farnesoid X
  receptor agonists, Intercept; 6ECDCA; UPF-747; obeticholic acid： OCA, Intercept; DSP-1747; FXR agonists, Intercept; INT-747; farnesoid Xreceptor agonists, Intercept; 6ECDCA; UPF-747; obeticholic acid
  
  Innovator: Intercept Pharmaceuticals Inc; Sumitomo Dainippon Pharma Co Ltd
  
  Inactive Companies： Universita di Perugia
  
  Sep, 2014, highest status: Phase 3 Clinical
  
  Active Indication: Liver disease; Primary sclerosing cholangitis; Alcoholic hepatitis; Primary biliary
  cirrhosis; Diarrhea; Portal hypertension; Non-alcoholic steatohepatitis
  
  Inactive Indications:Jaundice;Non alcoholic fatty liver disease
  
  Farnesoid X receptor agonist
  
  Other Actions: Anti-inflammatory; Bile acid modulator
  
  Technologies: Oral formulation; Small molecule therapeutic
  

• CAS Registry Number:

  459789-99-2

• Synonyms:

  ;6-ECDCA;6-Ethylchenodeoxycholic acid;Obeticholic Acid;

• Molecular Formula:

  C₂₆H₄₄O₄

• Molecular Weight:

  420.6252

• Molecular Structure:

  

• Company:

  SHANGHAI SHARING TECHNOLOGIES CO., LTD.     [ China ]        

• Contact:

  Zhang

• Tel:

  +86-21-56152668

• Fax:

  021-51861772

• Email:

  sharing@sharingtechcn.com